feed,title,long_url,short_url
Investors,Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug,https://www.investors.com/news/technology/srpt-stock-lifted-fda-decision-fast-track-dmd-drug-branch/,https://j.mp/3aU4Skt
